ArticleJCEM case reports2026
A late awakening: delayed functional transformation of a silent corticotroph adenoma into Cushing disease.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Silent corticotroph adenomas (SCAs) are a biologically distinct subset of nonfunctioning pituitary adenomas (NFPAs) characterized by corticotroph lineage without clinical or biochemical evidence of hypercortisolism. Although SCAs exhibit more aggressive growth behavior than other NFPAs, delayed transformation into overt adrenocorticotropic hormone (ACTH)-dependent hypercortisolism is rare. We describe a woman in her early 30s who presented with headaches and visual field deficits and was found to have a pituitary macroadenoma. Initial endocrine evaluation revealed mild hyperprolactinemia attributed to stalk effect, without evidence of hormonal hypersecretion. She underwent transsphenoidal surgery, and pathology was interpreted as an NFPA based on negative immunostaining. Transcription factor analysis was not performed. Postoperative imaging demonstrated a stable 5-mm residual lesion. More than 2 decades after surgery, progressive ACTH elevation emerged despite continued radiographic stability and preceded the development of clinical hypercortisolism by several years. Biochemical testing confirmed ACTH-dependent Cushing disease. Repeat surgery was performed and surgical pathology showed a T-box transcription factor-positive corticotroph adenoma with sparsely granulated ACTH expression. This case highlights the potential for very late functional transformation of SCAs and underscores the importance of long-term clinical and biochemical surveillance even in asymptomatic patients with stable residual disease on imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.